Ksilazin Vetconsult pharma 20 mg/ml raztopina za injiciranje
Ksilazin Vetconsult pharma 20 mg/ml raztopina za injiciranje
Authorised
- Xylazine
Product identification
Medicine name:
Ksilazin Vetconsult pharma 20 mg/ml raztopina za injiciranje
Active substance:
- Xylazine
Target species:
-
Cattle
-
Dog
-
Cat
-
Horse
Route of administration:
-
Intramuscular use
-
Intravenous use
Product details
Active substance and strength:
-
Xylazine20.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Cattle
-
Meat1dayMeso: 1 dan.
-
Milk0hourMleko: Nič ur.
-
-
-
Intravenous use
-
Cattle
-
Meat1dayMeso: 1 dan.
-
Milk0hourMleko: Nič ur.
-
-
Horse
-
Meat1dayMeso: 1 dan
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN05CM92
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Slovenia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Well-established use application (Article 13a of Directive No 2001/82/EC)
Marketing authorisation holder:
- Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
- Bioveta a.s.
Responsible authority:
- Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
- NP/V/0644/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Slovenian (PDF)
Published on: 15/02/2023
Package Leaflet and Labelling
This document does not exist in this language (English). You can find it
in another language below.
Slovenian (PDF)
Published on: 15/02/2023